1,583 results on '"Roccatello, Dario"'
Search Results
2. Relapsing Polycondritis
3. IgG4-Related Disease
4. Psoriatic Arthritis
5. Cryoglobulinemia and Emerging Related Disorders
6. Nephrological and Rheumatic Complications of Checkpoint Inhibitors
7. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial
8. Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies
9. Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure
10. Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease
11. Daratumumab monotherapy for refractory lupus nephritis
12. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
13. The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy
14. From inflammation to renal fibrosis: A one-way road in autoimmunity?
15. Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis?
16. Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review
17. Report on an Italian survey of 72 stuck hemodialysis catheters
18. Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies
19. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
20. Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management
21. Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
22. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
23. Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases
24. Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology
25. The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms?
26. “How we treat” clinical dilemmas in antiphospholipid syndrome: A case-based approach
27. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head
28. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion
29. Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
30. Pathogenesis-based new perspectives of management of ANCA-associated vasculitis
31. The role of kidney biopsy in the diagnosis of membranous nephropathy.
32. 2023 ACR/EULAR classification criteria in existing research cohorts: an international study.
33. Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome.
34. Differentiating between UCTD and early-stage SLE: from definitions to clinical approach
35. #1196 C3G and ic-MPGN across the life span: findings from the European Rare Kidney Disease Registry
36. #3108 Rituximab in adult-onset IgA vasculitis
37. #2265 The challenge of renal biopsy in diabetic patients: evaluation of a single center large cohort from North-West Italy
38. #2862 Genetics and electron microscopy: complementary tools for management of focal segmental glomerulosclerosis?
39. #2600 Idiopathic full-house non-lupus nephropathy
40. #2244 Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies
41. WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY
42. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
43. Lymphatic System and the Kidney: From Lymphangiogenesis to Renal Inflammation and Fibrosis Development
44. O25 Lupus podocytopathy: a rare form of lupus nephritis – an Italian retrospective multicenter study
45. P1 Intra-renal involvement in primary antiphospholipid antibodies syndrome: data from two Italian centers
46. Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience
47. The role of antirheumatics in patients with COVID-19
48. Diagnostic and Therapeutic Challenges in Rare and Complex Autoimmune Diseases
49. A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
50. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.